Your browser doesn't support javascript.
loading
External validation of first trimester combined screening for pre-eclampsia in Brazil: An observational study.
Rezende, Karina B de C; Bornia, Rita G; Rolnik, Daniel L; Amim, Joffre; Pritsivelis, Cristos; Cardoso, Maria Isabel M P; Gama, Luiza B; Crespo, Raquel A; L' Hotellier, Maria Carolina M P; da Cunha, Antônio José L A.
Affiliation
  • Rezende KBC; Clinical Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Multidisciplinary Laboratory of Epidemiology and Health - LAMPES, Federal University of Rio de Ja
  • Bornia RG; Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Professional Master Program in Perinatal Health, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.
  • Rolnik DL; Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia.
  • Amim J; Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Professional Master Program in Perinatal Health, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Ri
  • Pritsivelis C; Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.
  • Cardoso MIMP; Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Professional Master Program in Perinatal Health, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.
  • Gama LB; Professional Master Program in Perinatal Health, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.
  • Crespo RA; Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.
  • L' Hotellier MCMP; Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brasil.
  • da Cunha AJLA; Clinical Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; Multidisciplinary Laboratory of Epidemiology and Health - LAMPES, Federal University of Rio de
Pregnancy Hypertens ; 26: 110-115, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34739940
ABSTRACT

OBJECTIVE:

To validate a combined algorithm for early prediction of pre-eclampsia (PE) in the Brazilian population. STUDY

DESIGN:

This is an unplanned secondary analysis of a cohort study. Consecutive singleton pregnancies undergoing first-trimester screening for PE involving examination of maternal characteristics, medical history, and biophysical markers were considered eligible. Women were classified as low-or high-risk using a cutoff of 1/200, but the individual risk was not used to dictate management, as aspirin prophylaxis was given to women based solely on clinical risk factors. Receiver-operating characteristics (ROC) curves for PE, preterm PE(PE < 37) and early 34(PE < 34) were constructed and detection rates(DR) and false-positive rates(FPR) were calculated, adjusting for the effect of aspirin. Propensity score analysis was utilized to account for possible confounding by indication. MAIN OUTCOME

MEASURES:

Screening performance and PE rates.

RESULTS:

Among 1695 women, 323(19.1%) were classified as high-risk for PE and 1372(80.9%) were considered low-risk. Aspirin use was registered in 62(3.7%) in the high-risk group and 33(1.9%) in the low-risk group. There were 164(9.7%) women who developed PE, including 41(2.4%) with PE < 37 and 18(1.1%) PE < 34.Subgroups with aspirin had higher incidence of PE, suggest confounding by indication. The algorithm had an AUC of 0.87, DR of 72% for PE < 34; an AUC of 0.8, DR of 59% for PE < 37, both with FPR of 18%. Accounting for effect of aspirin, we observed an improvement in DR of PE < 37 to 67%.

CONCLUSION:

Using combined predictive algorithm for preterm PE prediction is feasible in clinical practice in low/middle-income countries. Aspirin use needs to be accounted for when evaluating the performance of screening.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pre-Eclampsia / Mass Screening Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Pregnancy Country/Region as subject: America do sul / Brasil Language: En Journal: Pregnancy Hypertens Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pre-Eclampsia / Mass Screening Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Pregnancy Country/Region as subject: America do sul / Brasil Language: En Journal: Pregnancy Hypertens Year: 2021 Document type: Article